Skip to main content

Treating the hype: supports and treatment responses for people impacted by methamphetamine use

Date: 
11 Nov. 2019
Where: 
Webinar on-demand

Australian Institute of Health and Welfare data list methamphetamine (MA) use second only to alcohol as the most common drug of concern in clients attending Alcohol and other Drug (AoD) services in Australia1. Whilst overall rates of MA use in Australia have remained stable in recent years, people who use MA are reporting higher rates of regular and dependent use, leading to complex physical, mental health and social problems.

The role of treatment and other interventions is crucial in addressing these, with residential rehabilitation, withdrawal management and counselling making up the current treatment options. The evidence base for stimulant-specific interventions and treatment is modest, but building, recognising the need for effective support that acknowledges the frequent experience of discrimination with this substance. This presentation will discuss where the AoD sector goes from here.

This bonus webinar is brought to you by Insight and NCCRED (National Centre for Clinical Research on Emerging Drugs).

The webinar from Insight - Centre for Alcohol and other Drug training and workforce development - Treating the hype: supports and treatment responses for people impacted by methamphetamine use, is available on demand and was delivered by Dr Suzie Hudson.